Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancer
Carolyn E. Reed(Medical University of South Carolina), Valerie W. Rusch(Memorial Sloan Kettering Cancer Center), Sandra Woolson(Durham VA Health Care System), Sin‐Ho Jung(Duke University), Katherine E. Posther(Duke University), Barry A. Siegel(Washington University in St. Louis), David H. Harpole(General Marble (Greece)), Gerard A. Silvestri(MUSC Hollings Cancer Center), Homer A. Macapinlac(International Atomic Energy Agency), Bryan F. Meyers(Washington University in St. Louis), Robert T. Heelan(Memorial Sloan Kettering Cancer Center), Robert J. Downey(Memorial Sloan Kettering Cancer Center)
Cited by 301
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Methods for Staging Non-small Cell Lung Cancer
|CHEST Journal|2013|1.5k
Selection Criteria for Lung-Cancer Screening
|New England Journal of Medicine|2013|1k
The Influence of Hospital Volume on Survival after Resection for Lung Cancer
|New England Journal of Medicine|2001|695